Response of seborrheic dermatitis, dandruff, and pyodermas to a form of sodium sulfacetamide.
D063807:Dandruff; D012628:Dermatitis, Seborrheic / Q000628:therapy*; D006801:Humans; D010915:Pityriasis; D011711:Pyoderma / Q000628:therapy*; D012625:Sebaceous Gland Diseases; D012627:Sebaceous Glands; D012871:Skin Diseases; D012964:Sodium; D013409:Sulfacetamide; D013449:Sulfonamides / Q000627:therapeutic use*
D013449:Sulfonamides; D013409:Sulfacetamide; D012964:Sodium
DERMATITIS SEBORRHEICA/therapy; PYODERMA/therapy; SEBACEOUS GLANDS/diseases; SKIN/diseases; SULFONAMIDES/therapeutic use